CCB International

CCB International (Holdings) Limited, a subsidiary of China Construction Bank Corporation, operates as an investment services firm. Its core business encompasses three primary areas: Pre-IPO, IPO, and Post-IPO, creating a comprehensive investment services value chain. CCB International provides a wide array of services, including sponsoring and underwriting, financial advisory, corporate mergers and acquisitions, restructuring, and additional issuance and placement of shares. The firm also engages in refinancing for listed companies, direct investment, asset management, securities brokerage, market research, and investment consultancy, catering to diverse client needs in the financial market.

Ruozhi Cheng

Senior Investment Manager

Fengzhi He

Senior Investment Manager

Hu Zhanghong Hu Zhanghong

Chief Executive Officer and Executive Director

Ke Ma

Chief Investment Director

Peter So

Managing Director and Head of Research

Rex Tang

Vice President

Xianbing Tang

Director

Yuanjie Yao

Senior Investment Manager

Coleman Yue

Associate

Junhua Zhu

Associate

58 past transactions

Chilye

Venture Round in 2022
Supplier of high voltage electrical appliances and power distribution units for new energy vehicles. The company focuses on the technical research and development, production of high-power electronic devices, high-voltage connections, and power distribution management in the field of electric vehicles, providing clients with solutions for complete vehicle systems.

Mirxes

Series C in 2022
MiRXES Pte. Ltd. develops life science research tools and molecular diagnostic tests or research and clinical diagnostic use. It offers RT-qPCR assays, assay panels, spike-in RNA kits, and biomarker discovery solutions. The company was founded in 2014 and is based in Singapore.

Tianbing Technology

Series B in 2022
Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.

Moore Threads

Series A in 2021
Moore Threads providing GPU (Graphics Processing Unit) technology and services to corporate clients in a wide variety of sectors such as gaming, the creative industry, and artificial intelligence.

Wego

Series A in 2021
Wego is a manufacturer of producing safe and affordable medical equipment.

Hozon

Series D in 2021
Hozon integrates hardware products and software services through innovative technology research and development, intelligent manufacturing, and multi-channel sales services. Through the development of electric, intelligence, and connectivity, they are committed to creating cost-effective Intelligent electric vehicles of high quality, providing users with a simple, intuitive, and comfortable travel experience.

SJ Semi

Series C in 2021
SJ Semi is a MEOL (Middle-End of Line) foundry which implements front-end wafer manufacturing and quality systems to MEOL operations. SJSemi's main business is providing bumping, Cu pillar, RDL, and testing services for 12" wafers. The company also places heavy R&D emphasis on fan-out, TSV, interposer, and 3D technologies.

IASO Biotherapeutics

Series C in 2021
Nanjing IASO Biotherapeutics is a clinical-stage biotechnology company established in 2017, specializing in the development of innovative therapies for cancer treatment. The company focuses on creating engineered autologous and allogenic T cell therapies aimed at enhancing the immune system's ability to identify and eliminate cancer cells. Its work centers on the discovery, development, and potential commercialization of cell therapies specifically in the oncology sector, striving to advance cancer care through these advanced therapeutic approaches. Based in Nanjing, China, IASO Biotherapeutics is dedicated to addressing the challenges posed by cancer through its targeted treatment solutions.

Orbusneich Medical

Series B in 2021
OrbusNeich Medical is a China-based global medical device manufacturer specializing in endovascular interventional instruments. Established in 2001 with its first research base, the company has achieved significant growth and was listed on the Hong Kong Exchange in 2022. As of 2023, its largest revenue segment comes from Japan, accounting for 24.7% of total revenue, followed closely by Europe, the Middle East, and Africa at 23.6%. The Asia-Pacific region and the United States contribute to the remainder of its revenue. OrbusNeich's primary product segment is coronary interventional medical devices, including scoring balloons, non-compliant balloons, and stents, which together comprise 82.7% of its total revenue.

Kuaikan Manhua

Series F in 2021
Kuaikan Manhua is an online and mobile platform for original online comic artwork targeting young readers. Founded in 2014, Kuaikan Manhua is a comic-reading platform and community of interest that is popular among users. As of January 2019, the total number of users of the comics app is over 170 million, and the monthly users are over 40 million, and the market share in the comics market is more than half*. Kuaikan World’s vision is to build an ideal ecosystem of cultural-entertainment in the future, as well as bring happiness to the world. Kuaikan aims to help comic creators to create more widely-popular comics with positive, energetic and warm contents to millions of users.

SVOLT

Series B in 2021
Svolt Energy Technology Co., Ltd. is a high-tech new energy company that specializes in energy technology, including electric vehicle battery (EVB) materials, cells, modules, PACK, BMS, energy storage system (ESS) and solar energy R&D and manufacturing. Headquartered in Wuxi, Jiangsu, SVOLT plans for 7 R&D centers around the globe, with four currently in operation, in Baoding, Korea, Shanghai and India, and three are under construction in the US, Japan and Wuxi. Domestically, SVOLT’s factory is under construction in Changzhou, Jiangsu, which will be operational by the end of 2019 with SOP in February 2020, and will have a capacity of 12GWh in 2020. Roadmap: SVOLT is pioneering the introduction of prismatic stacking batteries, making it the world’s first high-speed stacking prismatic battery maker. SVOLT aims to finish stacking one cell in 0.25 seconds in one single station. In contrast to the same type of winding process, the energy density of SVOLT stacking batteries improves 5%, the cycle life improves 10% and the cost reduces 15%.

Beijing Gene+ Technology

Series C in 2021
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the implementation of precision medicine. The company claims to operate in around 100 hospitals and have served thousands of cancer patients in China.
Shanghai Cell Therapy Group Co., Ltd., established in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company provides technical services and consulting, as well as technology transfer and investments within the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on areas such as cellular cold storage and cellular pharmaceuticals. Additionally, Shanghai Cell Therapy Group facilitates genetic testing for patients and supports cancer facilities by supplying essential research data.

Didi Woya

Series A in 2021
Didi Woya develop self-driving technology and related businesses.

DiDi Autonomous Driving

Private Equity Round in 2021
DiDi Autonomous Driving, focusing on advanced AD technology research and development, product application and other expanded businesses. DiDi’s advanced technologies, massive data, rich experience along with complete ecosystem in the mobility field will equip DiDi Autonomous Driving to build and operate world’s leading autonomous fleets.

Hinova Pharma

Series C in 2020
Hinova Pharmaceuticals Inc. is a drug discovery and development company focused on addressing unmet medical needs in China. Founded in 2013 and headquartered in Chengdu, with additional branches in Kowloon, Hong Kong, Houston, Texas, and Southbank, Australia, the company operates as a subsidiary of Haisco Pharmaceutical Group Co., Ltd. Hinova specializes in innovative drug research and development, utilizing advanced methodologies such as medicinal chemistry, biological screening, and clinical research. Its primary products include HC-1119, an androgen receptor antagonist, and HC-1102, an androgen receptor inhibitor, aimed at treating advanced prostate cancer and breast cancer.

Sinovent

Series C in 2020
Sinovent Inc. is a biopharmaceutical company founded in 2016 and headquartered in Suzhou, China, with additional offices in Beijing and Boston. The company is dedicated to innovation in healthcare, utilizing an advanced biotechnology platform and leveraging extensive management experience and financial resources. Sinovent focuses on developing and promoting advanced treatment methods to address global healthcare challenges. Currently, the company has 12 products in development, primarily targeting oncology, autoimmune diseases, and infectious diseases. Through its unique combination of scientific expertise, management acumen, and financial support, Sinovent aims to achieve excellence in the biopharmaceutical field.

Medical Data System

Series B in 2020
Thousand Oaks Biopharmaceuticals, Inc. is a biotechnology company based in Haimen, China, specializing in contract development and manufacturing services for the biopharmaceutical industry. Established in 2017, the company focuses on developing biopharmaceutical technologies that enhance the production of protein and vaccine compounds. It offers integrated control solutions designed to optimize production processes, improve protein expression, and reduce production scale. Additionally, Thousand Oaks provides personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services to its clients. The company also operates a healthcare receivable management platform that enhances patient collections, reduces operational costs, and increases revenue for healthcare providers through effective revenue cycle management and technology-driven solutions.

Shenzhen TargetRx

Series A in 2020
Shenzhen TargetRx, Inc. is a Sino-American joint venture established in 2014, focused on the research and development of targeted pharmaceuticals, particularly for cancer treatment. Based in Shenzhen, China, the company specializes in designing, screening, evaluating, and optimizing third-generation small molecule targeted anti-tumor drugs. It also conducts preclinical trials to advance its drug candidates. Founded by Dr. Yihan Wang, an experienced medical expert with extensive international credentials in small molecule targeted anti-cancer therapies, Shenzhen TargetRx aims to become a leading platform in this field. The company is dedicated to addressing challenges such as acquired drug resistance, with the goal of transforming cancer from a leading cause of death into a manageable chronic disease. Through its innovative approach, Shenzhen TargetRx seeks to develop original drugs with independent intellectual property rights, contributing significantly to the advancement of cancer treatment.

Intellifusion

Series C in 2020
Shenzhen IntelliFusion Technology Co., Ltd. develops artificial intelligence chips that specializes in visual artificial intelligence field and provides big data solutions to enterprises in areas like safe city, smart business, unmanned aerial vehicles, robotics, and intelligent manufacturing. The company manufactures facial recognition product "DeepEye" and has been adopted by Chinese public security systems for criminals identification. Shenzhen IntelliFusion Technology Co., Ltd. was founded in 2014 and is based in China.

Immunocore

Series B in 2020
Immunocore is a focused on the discovery and development of novel T cell receptor-based drugs to treat diseases with a high unmet need, including cancer and viral disease. The Company’s world-leading expertise in engineering T Cell Receptors (TCRs) and linking them to an antibody fragment (scFv) known as anti-CD3, has led to its first product candidate, IMCgp100, entering clinical trials in patients with metastatic melanoma. The proprietary T Cell Receptor technology platform is well validated and can easily be manufactured for clinical and commercial supply in microbial systems.
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Chengjia Apartment

Series A in 2019
Chengjia Apartment is a rental start-up that provides different product choices for apartments, hotels, and homestays. Chengjia Apartment extends the business scope to weekly rent, monthly rent, and long-term rent. The company creates a high-quality living environment with ingenuity, take care of every guest with hotel-style service, and creates a warm, comfortable, and temperature-friendly home. Chengjia Apartment is jointly established by China Living Hotel Group and IDG Capital. It has laid out nearly 100 properties in first-tier cities nationwide, with more than 10,000 houses and services. It was founded on 2015 and is headquartered in Shanghai, China.

Boston Micro Fabrication

Series A in 2019
BMF Precision is a micro-scale 3D printing system manufacturer dedicated to the development of micro-scale 3D printing systems and functional composites. Used in microfluidics, medical devices, electronics, and education.

Vapo Health

Series A in 2019
Vapo Health is a respiratory system health care device developer that uses nano-scale atomized micro-hole technology to ensure stable drug and particle power efficiency and provide users with atomization treatment services. Products include atomizer series, aerosol tank series, body temperature measurement series, intelligent breathing trainer, etc., as well as OEM and ODM services.

Inspur Cloud

Series B in 2019
Inspur Cloud, a subsidiary of Inspur Electronic Information Industry Co., Ltd., offers a range of cloud computing and data center solutions globally. The company specializes in cloud storage, databases, and disaster recovery services tailored for government bodies and enterprises. Founded in 2010 and headquartered in Jinan, China, Inspur Cloud provides advanced technologies, including artificial intelligence, high-performance computing, and various server and storage systems. In addition to its cloud offerings, the company also delivers software outsourcing services that encompass product development, migration, and web hosting. By serving diverse sectors, including finance, education, and manufacturing, Inspur Cloud meets the comprehensive information needs of its clients in both public and private domains.

Emirates National Oil Company

Debt Financing in 2019
Emirates National Oil Company (ENOC), a wholly-owned entity of the Dubai Government, is a leading force in the economic diversification and sustainable development of the UAE Established in 1993, ENOC’s primary focus has been to develop downstream and upstream activities in the oil and gas sector. Over the years, ENOC has expanded into several high-growth business sectors to create long-term value for its stakeholders.

Momenta

Series C in 2018
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offers multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of some of the world’s top experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. Momenta is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.

Pengyang Medical

Series A in 2018
Pengyang Medical is a health care service providing Medical.

Suning Sports

Series A in 2018
Suning Sports is a prominent segment of Suning Holdings Group, focusing on delivering top-tier products and services to sports enthusiasts. The company aims to establish itself as a leading international sports organization by leveraging its resources across various domains, including club management, sports media operations, youth training, copyright management, commercial activities, and real estate development. Suning Sports owns several football clubs, including Jiangsu Suning Football Club and F.C. Internazionale Milano, enhancing its influence in the sport. Additionally, its subsidiary, PP Sports, is the first Chinese sports media platform to secure exclusive broadcasting rights for Europe's top five football leagues, as well as other significant sporting events. Through these initiatives, Suning Sports is committed to elevating the sporting experience for fans while contributing to the broader sports industry in China.

Blocksteam

Series A in 2018
Blocksteam is a Gaming company.

LLVision

Series B in 2018
LLVISION was founded in 2014 by an elite team from Google, Lenovo, Microsoft, Intel, China Aeronautics, Nokia, Broadcom, etc.Their mission is to help the industry leaders intellectualize business processes through the first perspective innovation linked with multi-dimension connections, cognition and synergy and upgraded human-machine collaboration.

8Trip

Series C in 2018
8Trip, a China-based online travel service which connects suppliers with sellers. Currently, 8Trip covers the markets of Wuxi, Nanjing, and Anhui in China, and is planning to enter the Shanghai market next year. The company has partnerships with about 1,000 travel agencies and more than 4,000 service outlets. 8Trip was founded in December 2011 under the company name Octopus Online Tourism Development, with headquarters in Suzhou.

Oxford Nanopore Technologies

Venture Round in 2018
Oxford Nanopore Technologies Limited specializes in the development and commercialization of nanopore-based electronic systems for the analysis of single molecules, particularly in the fields of DNA and RNA sequencing. The company offers a range of products, including the portable MinION device for molecular analysis, the benchtop PromethION for large-scale sequencing projects, and the GridION system suitable for various molecular sensing applications. Their technology supports diverse scientific research areas such as genomics, cancer studies, microbiology, and environmental research, with applications extending to healthcare, agriculture, and food safety. The Flongle device caters to on-demand sequencing needs, while the MinIT accessory enhances the functionality of their sequencing devices. Oxford Nanopore’s innovative technology emphasizes accessibility and ease of use, with rapid library preparation and automated processes. Founded in 2005 and headquartered in Oxford, United Kingdom, the company operates additional offices worldwide, enabling its products to be utilized in over 80 countries.

Innocare

Venture Round in 2018
InnoCare Pharma Limited is a biopharmaceutical company focused on developing innovative treatments for cancer and autoimmune diseases. Founded in 2015 and headquartered in Wanchai, Hong Kong, InnoCare operates additional offices in major cities across China and in Cambridge, Massachusetts. The company is advancing several clinical programs, including Orelabrutinib, which targets various B-cell malignancies and is currently undergoing registrational trials. It is also developing ICP-192, a pan-inhibitor of fibroblast growth factor receptor, and ICP-105, which targets FGFR4 in advanced hepatocellular carcinoma. InnoCare's preclinical pipeline includes promising candidates aimed at treating specific cancer types and autoimmune disorders. The firm is supported by a highly qualified scientific team and a specialized advisory board, reinforcing its commitment to pushing the boundaries of drug innovation and improving patient outcomes.

Chezhency.com

Series B in 2018
Chezhency.com operates as a B2B auto trading platform, which integrates automotive logistics, supply chain finance, consumer credit, automobile insurance and other services. The company was founded in 2015 and is based in Shenzhen, China.
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

ByteDance

Series D in 2017
ByteDance is an Internet technology company that enables to discover a world of creative content platforms powered by leading technology. It owns a series of content platforms that enable people to connect with consuming and creating content through machine learning technology. With nearly 200 million daily active users each spends an hour every day on their products, the company is dedicated to building connections between people and information. Bytedance also operates a series of products popular with mobile users around the world, including Topbuzz, Flipagram, and a number of UGC short-form video apps. Bytedance was founded in March 2012 and is headquartered in Haidian, China, with offices in the USA and Japan.

CooTek

Series D in 2017
CooTek (NYSE: CTK), founded in 2008, listed on NYSE on September 28th, 2018, is a global and fast-growing mobile internet company that develops innovative mobile apps and artificial intelligence technology. With a massive global user base, CooTek aims to empower users to express themselves and enjoy relevant content seamlessly. CooTek’s flagship mobile app, TouchPal Keyboard, uses unparalleled technology to provide the best input experience to both Android and iPhone users. CooTek has also developed many content-rich apps, spanning across 5 selected verticals including fitness, lifestyle, healthcare, news and short videos, and entertainment. In September 2018, CooTek’s global products reached an average of 213.7 million monthly active users around the world. Headquartered in Shanghai, CooTek offices can be found in Silicon Valley, Beijing, Taipei, Guangzhou, and Shenzhen. Today, CooTek has over 170 patent applications and granted patents worldwide and continually pursue excellence in technology innovation and intellectual property development. CooTek has also established its own big data development center and AI lab in Silicon Valley. Many academic papers written by CooTek have been used in discussions at world-renowned big data and AI conferences such as AAAI, KDD and CIKM.

Face++

Series C in 2016
Incorporated in 2011, Megvii is committed to make greatest value for customers and the whole society with extraordinary technology. Megvii is an Artificial Intelligence company specialized in providing enterprises and developers with intelligent solutions and data services, and is dedicated to the mission of “Create machines that can see and think”. Based on its original deep learning system Brain++, Megvii seeks to build AI Engine, a core fundamental technology powering various AI application. It is leveraging on recognition, control, optimization and other algorithms to connect individuals, objects and scenarios, building a product platform of IoT OS. It is connecting standardized hardware like sensors, robots and personal devices with AI+IoT (AIoT), thus commercializing three application-oriented IoT brains on a large scale, namely, city brain, supply chain brain, and personal life brain. Megvii is building an operation system for the era of AIoT. Megvii is an AIoT solutions expert.

Shouqi Car Rental

Venture Round in 2016
Shouqi Rental Co., Ltd. is a private company providing integrated car rental services. The firm was founded in 1992 and is based in China.

Firstp2p

Series C in 2016
Firstp2p operates an online lending information platform. It provides financial products including car loans, mortgages, and financial leasing to small and medium enterprises. Firstp2p began operation in 2013, with its headquarters in Beijing in China.

Firefly Games

Venture Round in 2016
Firefly Games Inc. develops mobile games, such as tourivia, battle hatchers, fury fables, and dreamworks universe of legends. Firefly Games Inc. has a strategic partnership with MSM Corporation International Limited. The company was founded in 2015 and is headquartered in Los Angeles, California with additional offices in North America and Asia. As of May 7, 2020, Firefly Games Inc. operates as a subsidiary of Riva Technology and Entertainment Limited.

Weidong Cloud Education

Venture Round in 2016
Weidong Cloud Education Group aims to narrow the education gap between countries and regions, with the mission to boost education and technology for the benefit of the whole world as its mission. It uses “Cloud + Client” Integrated Solutions thatwhich passed the public test of the National Center for Educational Technology, to cooperatinge with global quality resources enterprises, application software companies and international top hardware service provider corporations to , builds Weidong International Education Cloud Industrial Park in Qingdao Blue Silicon Valley. With the, takes internet education industry as the core and , establishes5000 cabinets of cloud data center, buildings a global coverage, leading international educational cloud resource public service platform with global coverage.

Ant Group

Series B in 2016
Ant Group Co., Ltd. operates digital payments and digital finance platforms in the People’s Republic of China. The company operates Alipay, a digital payments platform; Yu'e Bao, an online spare cash management platform that puts user’s money into a money market fund managed by a partner asset management company and generates returns for the user; and Huabei, a consumer credit platform that supports buy now and pay later for consumers. Its products and services also include Xiang Hu Bao, an online mutual aid platform that provides a basic health plan to protect participants against 100 kinds of critical illnesses; MYbank, an online private bank that serves small and micro businesses, as well as individual entrepreneurs; and Zhima Credit, a private and independent credit assessment service for commercial use. The company was formerly known as Ant Small and Micro Financial Services Group Co., Ltd. and changed its name to Ant Group Co., Ltd. in July 2020. Ant Group Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, the People’s Republic of China.

Wellong Etown

Venture Round in 2016
Wellong Etown allows the clients to travel by car and ship all over the world, with high income and low cost for finding online smart load. Huilong installs a satellite positioning terminal for you with low fees and good service. The company finds empty trucks for your goods to be transported. It also transports online dispatching calls with high efficiency and punctuality.

Phylion Battery

Series A in 2015
Phylion Battery, based in Suzhou, China, specializes in the development, production, and sales of lithium-ion batteries, utilizing lithium manganate as the positive electrode material. The company has an annual production capacity of 5GWh and is recognized as a leading high-tech enterprise in the power lithium battery sector. With 15 years of successful technology transformation, Phylion has served 8 million end users and over 45,000 electric vehicles globally, providing power supply solutions for new energy vehicles and various industrial projects. In addition to manufacturing, Phylion is involved in related research and development activities in the energy storage sector.

Firstp2p

Series A in 2014
Firstp2p operates an online lending information platform. It provides financial products including car loans, mortgages, and financial leasing to small and medium enterprises. Firstp2p began operation in 2013, with its headquarters in Beijing in China.

Galloping Horse

Private Equity Round in 2011
Beijing Galloping Horse Film & TV Production Co., Ltd. produces and distributes films, TV series, and TV advertising solutions. It has a strategic partnership with Digital Domain Media Group, Inc. Beijing Galloping Horse Film & TV Production Co., Ltd. was founded in 2003 and is based in Beijing, China.

Green Leader

Convertible Note in 2010
Green Leader Holdings Group Ltd, is a mineral exploration and development company currently focused in Mongolia. Our principal business is focused on strategic investments in the mining sectors. The shares of the Company are listed on the main board of the Stock Exchange of Hong Kong Limited under stock code 61.